Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects

BACKGROUND: Lowering cholesterol levels decreases the risk of atherosclerotic diseases. Effective ways to stably reduce LDL-C level are warranted in type 2 diabetic patients, a high-risk population for CVD, with various anti-diabetic therapeutic background. The RESEARCH study focuses on LDL-C reduct...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Lipids Health Dis
Asıl Yazarlar: Sakamoto, Kentaro, Kawamura, Mitsunobu, Watanabe, Takayuki, Ashidate, Keiko, Kohro, Takahide, Tanaka, Akira, Mori, Yasumichi, Tagami, Motoki, Hirano, Tsutomu, Yamazaki, Tsutomu, Shiba, Teruo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5483302/
https://ncbi.nlm.nih.gov/pubmed/28646901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-017-0508-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller